A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
NCT ID: NCT04207580
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
850 participants
OBSERVATIONAL
2020-03-13
2045-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is to create a prospective cohort of pediatric INS patients to collect cases treated in SNP centers, to study their epidemiological characteristics, and to provide a basis for comparison for future cohort-nested trials.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Renal Replacement Therapy in Neonates
NCT05456659
Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome
NCT04169776
Sonographic Follow up in Newborns Diagnosed With Prenatal Hydronephrosis
NCT01780103
taVNS for FRNS in Children
NCT05588063
Ultrasonography Sensibilized by Oral Hydration and Hydronephrosis in Children.
NCT02086760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is therefore a prospective, multicenter, cohort follow-up study. The data will be centralized via a secure website dedicated to the study.
Data will be obtained from:
* Medical record data (hospitalization/consultations) as part of routine clinical follow-up for patients with active disease. This information will be medically validated and integrated into the database with the help of clinical research staff.
* A telephone interview for annual follow-ups for patients whose absence of active disease no longer requires a systematic medical visit. This structured interview will be administered by telephone by the study's clinical research staff.
* Self-administered or hetero-administered quality of life questionnaires (PEDS-QL), self-administered or hetero-administered treatment compliance questionnaires (Morisky's Score), and questionnaires on the aesthetic impact of treatments (Ferriman's Score). These questionnaires will be centralized and reported to the database by the study's clinical research staff.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inclusion and follow up of pediatric patients
Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome, from the beginning of the disease to 18 years old or transfer of the follow-up to a nephrology unit for adults.
130 new patients are expected to be included on an annual basis.
Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome,
The study consists in collecting clinical, biological, psychological and social data of INS pediatric patients.
A bio collection is also created: blood, urine, hair and nails will be collected at the beginning of the INS (before starting immunosuppressive treatment).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome,
The study consists in collecting clinical, biological, psychological and social data of INS pediatric patients.
A bio collection is also created: blood, urine, hair and nails will be collected at the beginning of the INS (before starting immunosuppressive treatment).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With idiopathic nephrotic syndrome (according to SPN criteria) beginning after January 1, 2018
* Child seen at least once in consultation or hospitalization by a pediatrician member of the Society of Pediatric Nephrology
* Residing in France
* Consent signed by parents and patient's agreement to participate (if of age)
* Affiliated to a social security system.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent Guigonis, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Limoges
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Limoges Hospital
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Bahans C, Boyer O, Dunand O, Parmentier C, Ranchin B, Roussey G, Samaille C, Tellier S, Vrillon I, Preka E, Meriguet T, Dubrasquet A, Ichay L, Clave S, Bernardor J, Merieau E, Dossier C, Guigonis V. A "Trial within a Cohort" platform for pediatric clinical trials on idiopathic nephrotic syndrome: scope, objectives, and design of the retrospective-prospective cohort PIN'SNP. Pediatr Nephrol. 2025 Jul;40(7):2225-2238. doi: 10.1007/s00467-025-06676-7. Epub 2025 Mar 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
87RI19_0006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.